âAfter more than a decade of joint respiratory research and development, the approval is a very important milestone for Theravance and GSK.â. Following this approval by the FDA, it is anticipated that BREO ELLIPTA will be available in the US during the third quarter of 2013. Under the terms of the 2002 LABA collaboration agreement, Theravance is obligated to make a milestone payment of $30 million (USD) to GSK following FDA approval of BREO ELLIPTA.
More on The Christian Science Monitor. The Christian Science Monitor is an independent international news organization with the stated goal of understanding the worldâs problems in order to move toward solutions. Mary Baker Eddy, the founder of Church of Christ, Scientist, founded the Christian Science Monitor in 1908.
The heart event monitor, also known as the cardiac event recorder, is a battery-powered portable instrument used to monitor and record the heartâs electrical activity (ECG) when the patient is experiencing symptoms such as dizziness, shortness of breath, palpitations, and chest pain. Consider buying a refurbished heart event monitor device. 2  It is usually offered at a fraction of the price of a new unit, enabling you to save on the cost of the item. 3  But be sure that the refurbished device works efficiently and that it comes with a warranty from the seller.